Format

Send to

Choose Destination
J Dig Dis. 2019 Feb;20(2):54-61. doi: 10.1111/1751-2980.12707. Epub 2019 Mar 10.

Chinese consensus on the clinical application of hepatobiliary magnetic resonance imaging contrast agent: Gadoxetic acid disodium.

Author information

1
Department of Radiology, Zhongshan Hospital, Fudan University, and Shanghai Institute of Medical Imaging, Shanghai, China.
2
Department of Radiology, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong Province, China.
3
Department of Radiology, Southwest Hospital, Third Military Medical University, Chongqing, China.
4
Department of Radiology, Guangzhou First People's Hospital, Guangzhou, Guangdong Province, China.
5
Department of Radiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China.
6
Department of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong Province, China.
7
Department of Radiology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.
8
Department of Radiology, Tianjin First Central Hospital, Tianjin, China.
9
Department of Diagnostic Imaging, Chinese Academy of Medical Sciences Cancer Hospital, Beijing, China.
10
Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.
11
Department of Radiology, The First Hospital of Jilin University, Changchun, Jilin Province, China.
12
Department of Radiology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi Province, China.
13
Department of Radiology, Guangdong Provincial People's Hospital, Guanggong Academy of Medical Sciences, Guangzhou, Guangdong Province, China.

KEYWORDS:

China; consensus; gadolinium ethoxybenzyl DTPA; imaging techniques; magnetic resonance imaging

PMID:
30693659
DOI:
10.1111/1751-2980.12707

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center